This announcement is a separate document:
金陵药业：江苏泰和律师事务所关于金陵药业股份有限公司2021年限制性股票激励计划回购价格调整及回购注销部分限制性股票的法律意见书
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on Jinling Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan Repurchase Price Adjustment and Repurchase Cancellation of Some Restricted Shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.